1
Return

On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19

delete2025-01-01
delete0
PRE
AI
L
Lana Wahid *
J
Joshua Froess
T
Thomas L. Ortel
R
Ryan Zarychanski
J
Jeffrey S. Berger
M
Mary Cushman
D
Derek C. Angus
V
Valerie J. Renard
P
Parisa Farahani
S
Steve Webb
A
Anna Heath
L
Lucas C. Godoy
M
Michael E. Farkouh
J
Judith S. Hochman
M
Matthew D. Neal
P
Patrick R. Lawler
DOI：10.1161/ATVBAHA.124.321108delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En
Keywords:
COVID-19
critical care
heparin
precision medicine
thromboinflammation

Journal

Arteriosclerosis Thrombosis and Vascular Biology cover
Arteriosclerosis Thrombosis and Vascular Biology
IF:
7.4
Papers:
1.2W
Citations:
3.5W

Organization

D
Duke University
Scholars:
6.3W
Papers: 5.7W
Citations: 6.5W
M
Monash University
Scholars:
5.4W
Papers: 5.4W
Citations: 79
H
hospital for sick children (sickkids)
Scholars:
1.1W
Papers: 8.1K
Citations: 16
C
cancercare manitoba foundation
Scholars:
724
Papers: 483
Citations: 0
U
University of Pittsburgh
Scholars:
4.5W
Papers: 3.6W
Citations: 7.1W
P
pennsylvania commonwealth system of higher education (pcshe)
Scholars:
12.8W
Papers: 11.7W
Citations: 176
U
university of vermont
Scholars:
1.1W
Papers: 9.6K
Citations: 17
U
university of toronto
Scholars:
14.5W
Papers: 11.9W
Citations: 165
Cited Papers

Cited Papers

Citing Papers

Citing Papers